Skip to main content
Premium Trial:

Request an Annual Quote

CollabRx Inks Distribution Partnership with Projects In Knowledge

Premium

CollabRx said this week that is has signed a multi-year agreement with Projects In Knowledge, a developer of digital and mobile information tools and continuing medical education programs, to jointly distribute software applications to over 35,000 oncologists and clinicians in its clinician network.

Under the terms of the agreement, the partners will integrate CollabRx's Therapy Finder applications into Projects In Knowledge's @Point of Care360 platform, an interactive medical textbook that gives clinicians access to educational resources.

CollabRx's Therapy Finder is a series of web-based applications for oncology that help clinicians and their patients select the most appropriate treatments for tumors. These apps use data from an underlying proprietary knowledgebase that the company has developed that contains aggregated data from multiple public sources including published papers, conference abstracts, clinical trials, and diagnostic guidelines (BI 2/22/2013).

The partners said that they will seek support from pharmaceutical and biotechnology companies in the form of educational grants to conduct their initial activities and that they will explore other fundraising mechanisms to support later phases of the partnership.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more